A Study of RC98 in Subjects With Advanced Malignant Solid Tumors

NCT04190823 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: RC98

Sponsor

RemeGen Co., Ltd.